Timothy Mark Turner

Title: Innovations of Timothy Mark Turner

Introduction

Timothy Mark Turner is a notable inventor based in Boulder, CO. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of CRF receptor antagonists. With a total of 2 patents to his name, Turner continues to push the boundaries of innovation in his field.

Latest Patents

Turner's latest patents include groundbreaking work on cyclic compounds and nitrogen-containing fused heterocyclic compounds. His patent on cyclic compounds describes a CRF receptor antagonist comprising a specific compound formula. The second patent focuses on nitrogen-containing fused heterocyclic compounds, detailing a CRF receptor antagonist with a complex structure involving various chemical elements and configurations.

Career Highlights

Timothy Mark Turner is currently employed at Takeda Pharmaceutical Company Limited, where he applies his expertise in drug development. His work has been instrumental in advancing therapeutic options for various medical conditions. His innovative approaches have garnered attention in the pharmaceutical industry.

Collaborations

Some of Turner's notable coworkers include Albert Charles Gyorkos and Christopher Peter Corrette. Their collaborative efforts contribute to the success of the projects they undertake at Takeda Pharmaceutical Company Limited.

Conclusion

Timothy Mark Turner exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative work continue to impact the field positively.